Dr. Radomsky is a pharmaceutical industry scientist and executive with nearly 30 years of experience in a broad scope of leadership, technical, regulatory, entrepreneurial, and consulting roles. His expertise results from his PhD in chemical engineering from The Johns Hopkins University and leading the formulation development, manufacturing, and commercialization activities of small molecule, peptide, and protein drugs. Mike focused his early research efforts on the development of using polymers to deliver drugs in a controlled release fashion and completed his dissertation on the use of polymers to deliver antibodies for the prevention and treatment of infectious diseases.
Mike has demonstrated success in advancing generic and innovator product pipelines from discovery to launch utilizing a wide variety of resources. By leading large and small groups of cross functional teams, he has developed a keen understanding of the unique dynamics between research, development, manufacturing, quality, clinical, and the regulatory functions required to develop and manufacture FDA regulated pharmaceutical products. He is a co-founder of CMC Pharma, and currently President of CMC Pharma serving as Principal Investigator for DoD funded and other research, development, and manufacturing programs.